Brief: Creso Pharma Says Unit Exploring Opportunities For Australian Market
07/02/2023 24:23
Feb 7 (Reuters) - Creso Pharma Ltd CPH.AX :
* HALUCENEX LIFE SCIENCES EXPLORING OPPORTUNITIES TO
REGISTER ITS
SYNTHETIC PSILOCYBIN FORMULATION FOR AUSTRALIAN MARKET
Source text for Eikon: ID:nASX7p4jtx
Further company coverage: CPH.AX
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale